Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |